Navigation Links
Optimal surgical procedure for duodenal gastrointestinal stromal tumors
Date:6/24/2010

Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the digestive tract. However, the duodenal location is less common. Nowadays, surgery is still the only curative approach for GIST. Numerous procedures can be performed to remove duodenal GIST. Some of these operations are extensive and require difficult reconstruction (like pancreaticoduodenectomy; PD). One of the options is a more limited intervention: segmental duodenectomy (SD). However, few studies have correlated the different surgical options with the oncological results.

A research article to be published on June 14, 2010 in the World Journal of Gastroenterology addresses this question. A Switzerland research group has conducted this study to evaluate the outcomes after SD and PD. They found that SD was a reliable and curative option for most duodenal GISTs, and was compatible with long-term disease-free survival (DFS). On the other hand, PD remains a good alternative for tumors in the vicinity of the pancreas.

In the present study, the authors report good oncological outcomes with long-term DFS in the SD group. Thus, whenever associated with clear surgical margins, SD is a reliable and curative option for most duodenal GISTs.


'/>"/>

Contact: Lin Tian
wjg@wjgnet.com
86-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

Page: 1

Related medicine news :

1. Findings suggest optimal dose
2. 6 to 8 Hours of Shut-Eye Is Optimal for Health
3. In the green of health: Just 5 minutes of green exercise optimal for good mental health
4. Sleep Study Shows Pillo1 Re-Educates Body to Naturally Move Into Optimal Sleep Position and Increases REM Sleep by 21.3%
5. Spectrum Surgical Instruments Appoints President, Chief Operating Officer
6. GYN Oncologist Uses da Vinci Surgical Robot to Preserve Fertility
7. Spectrum Surgical Instruments Corp. Announces: Cleanables™ Instrument Cleaning Brushes
8. Jackson Surgical Assistants Expands Its National Presence by Merging with Two Atlanta Area Practices
9. Surgical procedure offers new option for pediatric patients with rare cancer in abdomen
10. Relationships May Influence Surgical Residents Career Plans
11. Dr. Alexander Rivkin's Pioneering Non-Surgical Nose and Eye Transformations Are Making Headlines and May Be Permanent Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... Birmingham, Lake Orion, Clarkston, Michigan (PRWEB) , ... ... ... their direction with respect to fertility once they have been diagnosed with endometriosis. ... for tolerable intercourse but they also require a comprehensive approach that can help ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Consumers have taken a more ... placed more emphasis on patient outcomes. ... in the pharmaceutical industry have evolved beyond just ... companies are focusing on becoming more patient-oriented across ... and services that improve health. ...
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... , June 24, 2016 ... Markets has announced the addition of the " ... offering. This ... and provides an updated review, including its applications in ... the total market, which includes three main industries: pharmaceutical ...
Breaking Medicine Technology: